Risperdal Consta 37,5 mg prolonged release suspension for intramuscular Injection


Prolonged release suspension for intramuscular Injection
scheduling status
S5
registration number
37/2.6.5/0143
What Risperdal Consta 37,5 mg prolonged release suspension for intramuscular Injection contains
Risperidone.
other ingredients
RISPERDAL CONSTA is an extended release microspheres formulation of risperidone, composed of risperidone drug substance micro-encapsulated in polylactide-co-glycolide, at a concentration of 381 mg risperidone per gram of microspheres.
Therapeutic classification
A.2.6.5 Central nervous system depressants.
Risperdal Consta 37,5 mg prolonged release suspension for intramuscular Injection
© 2026 SAHPRA. ALL RIGHTS RESERVED